Welcome to the Washington State Medical Oncology Society Website

The purpose of the Washington State Medical Oncology Society (WSMOS) is:

  • To promote the highest professional standards of oncology practice in the state of Washington.
  • To study, research and exchange information, experiences and ideals leading to improvement in the practice of oncology.
  • To represent the practice of oncology and hematology in the state of Washington.

Regularly Monitor the WSMOS Website for:

  • WSMOS meetings & events
  • Legislative updates
  • Billing & reimbursement updates
  • Resources & tools
  • Oncology news
  • Newsletter
  • Practice Pattern Changes Survey

Join Your Colleagues at the November 16, 2012 Membership Meeting at the beautiful Cedarbrook Lodge ~ Meeting Agenda and registration will be available on the Events page of this website.

Recovery Audit Contractor (RAC) Preparation & Process

Click Here to access the WSMOS RAC Preparation & Process Brochure funded in part through the ASCO 2010 State Affiliate Grant Program

You are Invited to Attend: 

 From ACO to Medical Home: Emerging Care Delivery Models - Sponsored by Astellas

This presentation will cover the following topics

  • Accountable Care Organizations (ACOs)
  • Patient-Centered Medical Home (PCMH) Programs
  • Patient-Centered Specialty Practice (PCSP) Programs

Learn more about these initiatives and the importance of quality measures.

Click Here for a detailed agenda of topics that will be presented. 

This program will be presented by:

Mina Harkins
Assistant Vice President, Recognition Programs Policy National Committee for Quality Assurance

Wednesday, February 25, 2015
6:30 PM

 El Gaucho
2505 First Avenue
Seattle, WA

For more information on this program contact Sue Miller, Astellas Pharma, Inc. at sue.miller@astellas.com or 303.956.3713


Diamond Partners See All

  • Amgen
  • Astellas Pharma US
  • Bayer Healthcare
  • Celgene
  • Genetech BioOncology
  • Genomic Health
  • Incyte
  • Lilly Oncology
  • Millennium
  • Myriad
  • Onyx Pharmaceuticals/
  • Pfizer Oncology
  • Sanofi Aventis
  • Teva Oncology